Journal of Surgery Concepts & Practice ›› 2019, Vol. 24 ›› Issue (02): 141-148.doi: 10.16139/j.1007-9610.2019.02.012
• Original article • Previous Articles Next Articles
CAO Lichen1, TIAN Baoxing1, QU Feilin1, ZHANG Qinghua2, GUO Shanyu1
Received:
2018-12-03
Online:
2019-03-25
Published:
2019-04-25
CLC Number:
CAO Lichen, TIAN Baoxing, QU Feilin, ZHANG Qinghua, GUO Shanyu. Study on serum exosome proteins in metastatic breast cancer patients[J]. Journal of Surgery Concepts & Practice, 2019, 24(02): 141-148.
[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424. [2] Duffy MJ, Walsh S, McDermott EW, et al. Biomarkers in breast cancer: where are we and where are we going?[J]. Adv Clin Chem,2015,71:1-23. [3] Paget S.The distribution of secondary growths in cancer of the breast. 1889[J]. Cancer Metastasis Rev,1989,8(2):98-101. [4] Balaj L, Lessard R, Dai L, et al.Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences[J]. Nat Commun,2011,2:180. [5] Cheung KL, Robertson FR.Objective measurement of remission and progression in metastatic breast cancer by the use of serum tumour markers[J]. Minerva Chir,2003, 58(3):297-303. [6] Kurebayashi J, Nishimura R, Tanaka K, et al.Significance of serum tumor markers in monitoring advanced breast cancer patients treated with systemic therapy: a prospective study[J]. Breast Cancer,2004,11(4):389-395. [7] Molina R, Auge JM, Escudero JM, et al.Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value[J]. Tumour Biol,2010,31(3):171-180. [8] Hoshino A, Costa-Silva B, Shen TL, et al.Tumour exosome integrins determine organotropic metastasis[J]. Nature,2015,527(7578):329-335. [9] Peinado H, Aleckovic M, Lavotshkin S, et al.Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET[J]. Nat Med,2012, 18(6):883-891. [10] Greening DW, Xu R, Ji H, et al.A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods[J]. Methods Mol Biol,2015,1295:179-209. [11] Lee HD, Koo BH, Kim YH, et al.Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes[J]. FASEB J,2012,26(7):3084-3095. [12] Fu H, Yang H, Zhang X, et al.Exosomal TRIM3 is a novel marker and therapy target for gastric cancer[J]. J Exp Clin Cancer Res,2018,37(1):162. [13] Felding-Habermann B, Cheresh DA.Vitronectin and its receptors[J]. Curr Opin Cell Biol,1993,5(5),864-868. [14] Preissner KT, Seiffert D.Role of vitronectin and its receptors in haemostasis and vascular remodeling[J]. Thromb Res,1998,89(1):1-21. [15] 梁晓芸, 李文学, 陈建玲, 等. 玻连蛋白促进肝癌细胞株增殖及迁移的初步研究[J]. 癌变、畸变、突变,2014, 26(1):30-34,39. [16] Pola C, Formenti SC, Schneider RJ.Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells[J]. Cancer Res,2013,73(14):4571-4578. [17] Preissner KT, Reuning U.Vitronectin in vascular context: facets of a multitalented matricellular protein[J]. Semin Thromb Hemost,2011,37(4):408-424. [18] Li R, Luo M, Ren M, et al.Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis[J]. J Vasc Res,2014,51(2):110-117. [19] Pirazzoli V, Ferraris GM, Sidenius N.Direct evidence of the importance of vitronectin and its interaction with the urokinase receptor in tumor growth[J]. Blood,2013,121(12):2316-2323. [20] Chao J, Tillman DM, Wang MY, et al.Identification of a new tissue-kallikrein-binding protein[J]. Biochem J,1986, 239(2):325-331. [21] Zhou GX, Chao L, Chao J.Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence[J]. J Biol Chem,1992,267(36):25873-25880. [22] Chen VC, Chao L, Chao J.Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein[J]. J Biol Chem,2000, 275(49):38457-38466. [23] Miao RQ, Chen V, Chao L, et al.Structural elements of kallistatin required for inhibition of angiogenesis[J]. Am J Physiol Cell Physiol,2003,284(6):C1604-C1613. [24] Shen B, Gao L, Hsu YT, et al.Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling[J]. Am J Physiol Heart Circ Physiol,2010,299(5):H1419-H1427. [25] Gao L, Li P, Zhang J, et al.Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells[J]. J Am Heart Assoc,2014,3(5):e001194. [26] Chao J, Li P, Chao L.Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress[J]. Biol Chem,2017,398(12):1309-1317. [27] Kontrogianni-Konstantopoulos A, Bloch RJ.Obscurin: a multitasking muscle giant[J]. J Muscle Res Cell Motil,2005,26(6-8):419-426. [28] Kontrogianni-Konstantopoulos A, Ackermann MA, Bowman AL, et al.Muscle giants: molecular scaffolds in sarcomerogenesis[J]. Physiol. Rev,2009,89(4):1217-1267. [29] Perry NA, Ackermann MA, Shriver M, et al.Obscurins: unassuming giants enter the spotlight[J]. IUBMB Life,2013,65(6):479-486. [30] Sjoblom T, Jones S, Wood LD, et al.The consensus co-ding sequences of human breast and colorectal cancers[J]. Science,2006,314(5797):268-274. [31] Perry NA, Shriver M, Mameza MG, et al.Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance[J]. FASEB J,2012,26(7):2764-2775. |
[1] |
FU Wen, WANG Xiangchen, WANG Yangui, et al.
Mechanism research of adipose-derived mesenchymal stem cell-derived exosomes in wound healing of full-thickness skin defect in rats [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(4): 342-. |
[2] | LI Hui, YIN Yu, LI Chunxiao, et al. Research progress on rehabilitation effect of respiratory training on breast cancer-related lymphedema [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(4): 430-. |
[3] | ZHAO Hui (赵晖),WEN Baiqing (文柏清),KANG Yani*(康亚妮). Gene Expression Profiling Identifies Potential Biomarkers for Colorectal Cancer Using NanoString nCounter Assay [J]. J Shanghai Jiaotong Univ Sci, 2023, 28(4): 432-. |
[4] | JIA Jingyil (贾菁怡),LI Zhengyi1,2 (李正裔),PENG Linjing1 (彭琳晶),YAO Yifeil* (姚怡飞). Early Detection Methods of Deep Tissue Pressure Injuries: A Systematic Review [J]. J Shanghai Jiaotong Univ Sci, 2023, 28(4): 526-. |
[5] | QIU Yucheng, ZHOU Xianyu, LIU Fei, et a. Application progress of mesenchymal stem cells and their exosomes in allotransplantation [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(2): 184-. |
[6] | ZHU Danli, BAO Wanting, WEI Hao, et al. Advances in breast reconstruction after breast cancer surgery [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(2): 201-. |
[7] | ZHU Qiaoli, MIAO Yiming, CHEN Xiaosong. Prognostic analysis of breast-conserving surgery or mastectomy in patients with stage Ⅰ-Ⅲ triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 371-377. |
[8] | YANG Yi, YANG Xingxia, JIN Sili, ZHANG Xu, ZHU Juanying, CHEN Xiaosong. Clinical application of preoperative MRI examination in breast-conserving surgery for ductal carcinoma in situ [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 378-382. |
[9] | DONG Jun, CUI Fengming, LIU Jun. Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 254-259. |
[10] | GAO Weiqi, ZHANG Xu, WANG Zheng, ZHU Yifei, HUANG Jiahui, HONG Jin, ZHU Siji, CHEN Xiaosong, HUANG Ou, HE Jianrong, CHEN Weiguo, LI Yafen, SHEN Kunwei, XU Hua, WU Jiayi. Safety analysis of immediate breast reconstruction with deep inferior epigastric perforator after neoadjuvant treatment [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 147-151. |
[11] | FAN Qingquan, SONG Xiaoling, GU Jun. Exosome in gastric cancer: research and perspective [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 177-180. |
[12] | CHEN Guoqun, CAI Jiaodi. Interpretation of the Clinical Practice Guidelines for Non-small Lung Cancer (version 4 and version 5) of 2022 National Comprehensive Cancer Nerwork(NCCN) [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(01): 8-13. |
[13] |
ZHANG Xiaoli, LI Zan, SONG Dajiang, et al.
Clinical application of the pedicled lateral thoracic artery perforation flap in breast reconstruction immediately after breast-conserving surgery [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 382-. |
[14] |
SONG Dajiang, LI Zan, ZHANG Yixin.
Surgical strategy of huge chest wall defect reconstruction using pedicled rectus abdominis musculocutaneous flap combined with free deep inferior epigastric artery perforator flap [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 386-. |
[15] |
CHEN Kuo, SONG Dajiang, MU Lan, et al.
Repair of abdominal wall donor site defect of TRAM by freeing the anterior rectus sheath of superior rectus abdominis -- An attempt to make patch with autologous tissue [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 393-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||